Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY 4.0Revista Brasileira de Ginecologia e Obstetrícia

Clinical treatment of tubal pregnancy with methotrexate: a comparison of intramuscular and intravenous routes in a randomized clinical trial

6 affiliations
  1. 1Universidade Federal do Paraná Curitiba PR Brazil Universidade Federal do Paraná, Curitiba, PR, Brazil.
  2. 2Universidade Federal de São Paulo Escola Paulista de Medicina São Paulo SP Brazil Escola Paulista de Medicina- Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  3. 3Universidade Municipal de São Caetano do Sul São Caetano do Sul SP Brazil Universidade Municipal de São Caetano do Sul, São Caetano do Sul, SP, Brazil.
  4. 4Universidade Federal do Rio de Janeiro Rio de Janeiro RJ Brazil Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
  5. 5Universidade Federal do Estado do Rio de Janeiro Rio de Janeiro RJ Brazil Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  6. 6Universidade de Vassouras Vassouras RJ Brazil Universidade de Vassouras, Vassouras, RJ, Brazil.

Abstract

Objective:: To compare the intravenous and intramuscular administration routes of methotrexate in the clinical treatment of tubal pregnancy.

Methods:: A prospective randomized clinical trial was conducted, including women with an indication for medical management of tubal pregnancy, comparing the use of methotrexate via intravenous and intramuscular routes (50 mg/m² of body surface area). The analyzed outcome was treatment success (good outcome), defined as a 15% decrease in β-hCG levels between days 1 and 7. Treatment failure was defined as the need for surgical intervention due to suspicion or confirmation of ruptured tubal pregnancy.

Results:: A total of 107 cases of tubal pregnancy were included, divided into the intravenous group (n = 48) and the intramuscular group (n = 59). The mean age of the women was 28.1 years (range, 18–40). The mean mass size was 21.8 mm (range, 7–49 mm), and the median [Q1–Q3] initial serum β-hCG value was 1361,15 mU/mL (584,58–2382,45). No significant differences were found between the groups regarding treatment success or failure outcomes, nor in adverse effects. The treatment success rates in the intravenous and intramuscular groups were 74.6% and 79.2%, respectively.

Conclusion:: The intravenous and intramuscular routes for the clinical treatment of tubal pregnancy with methotrexate were equivalent in treatment success outcomes, with no difference observed in the reduction of serum β-hCG levels.

Brazilian Clinical Trials Registry (ReBEC):: # RBR-7nkf8tn

Related

  1. Comparison of remimazolam total intravenous anesthesia versus sevoflurane inhalational anesthesia on emergence agitation in patients undergoing laparoscopic surgery for gastric or colorectal cancer: study protocol for a randomized controlled trial
    Wenjie Mao, Binbin Yang, Fan Huang +3
    TrialsPeer-reviewedCC BY 4.0Clinical trials & evidence synthesisCrossref
  2. Comparison of CT-Guided Platelet-Rich Plasma vs Steroid/Anesthetic Injection for Treatment of Sacroiliac Joint Pain: A Randomized, Single-Blinded, Controlled Trial
    Miriam E. Peckham, Zachary L. McCormick, Ghazaleh Safazadeh +3
    AJNR: American Journal of NeuroradiologyPeer-reviewedCC BYFull textSurgery & anaesthesiaPMC
  3. Optimal strategy for treatment of atherosclerotic cardiovascular disease—comparison of clopidogrel-based antiplatelet agent treatment versus aspirin plus low dose rivaroxaban therapy (OACART study): a study protocol for a multicenter, open-label, randomized, non-inferiority trial
    Ju-Seung Kwun, Chang-Hwan Yoon, Ki-Hyun Jeon +30
    TrialsPeer-reviewedCC BY-NC-ND 4.0Full textCardiovascular medicinePMC
  4. Comparable efficacy of extraoral and intraoral photobiomodulation in preventing oral mucositis during high-dose methotrexate therapy in pediatric oncology: A single-blind randomized controlled trial.
    Isabela de Oliveira Plugge Freitas, Isabela Schuartz, Giovanna Leal Klein Renz +5
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Perioperative intravenous lidocaine for the prevention of chronic postsurgical pain: a systematic review and meta-analysis of randomized controlled trials
    Wei-Jing Zhu, Ran An, Qian-Yun Pang +1
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{mello2026clinical,
  title = {{Clinical treatment of tubal pregnancy with methotrexate: a comparison of intramuscular and intravenous routes in a randomized clinical trial}},
  author = {Paula Vieira de Mello and Edward Araujo Júnior and Eduardo Moreira Nader and Beatriz Bussi Rosolen and Julio Elito and Antonio Braga and Barbara Milena Marciniak and Eduardo Schunemann and Rafael Frederico Bruns},
  journal = {Revista Brasileira de Ginecologia e Obstetrícia},
  year = {2026},
  month = oct,
  doi = {10.61622/rbgo/2026rbgo78},
  url = {https://doi.org/10.61622/rbgo/2026rbgo78},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Clinical treatment of tubal pregnancy with methotrexate: a comparison of intramuscular and intravenous routes in a randomized clinical trial
AU  - Paula Vieira de Mello
AU  - Edward Araujo Júnior
AU  - Eduardo Moreira Nader
AU  - Beatriz Bussi Rosolen
AU  - Julio Elito
AU  - Antonio Braga
AU  - Barbara Milena Marciniak
AU  - Eduardo Schunemann
AU  - Rafael Frederico Bruns
PY  - 2026
DA  - 2026/10/30
JO  - Revista Brasileira de Ginecologia e Obstetrícia
DO  - 10.61622/rbgo/2026rbgo78
UR  - https://doi.org/10.61622/rbgo/2026rbgo78
AB  - Objective:: To compare the intravenous and intramuscular administration routes of methotrexate in the clinical treatment of tubal pregnancy.  Methods:: A prospective randomized clinical trial was conducted, including women with an indication for medical management of tubal pregnancy, comparing the use of methotrexate via intravenous and intramuscular routes (50 mg/m² of body surface area). The analyzed outcome was treatment success (good outcome), defined as a 15% decrease in β-hCG levels between days 1 and 7. Treatment failure was defined as the need for surgical intervention due to suspicion or confirmation of ruptured tubal pregnancy.  Results:: A total of 107 cases of tubal pregnancy were included, divided into the intravenous group (n = 48) and the intramuscular group (n = 59). The mean age of the women was 28.1 years (range, 18–40). The mean mass size was 21.8 mm (range, 7–49 mm), and the median [Q1–Q3] initial serum β-hCG value was 1361,15 mU/mL (584,58–2382,45). No significant differences were found between the groups regarding treatment success or failure outcomes, nor in adverse effects. The treatment success rates in the intravenous and intramuscular groups were 74.6% and 79.2%, respectively.  Conclusion:: The intravenous and intramuscular routes for the clinical treatment of tubal pregnancy with methotrexate were equivalent in treatment success outcomes, with no difference observed in the reduction of serum β-hCG levels.  Brazilian Clinical Trials Registry (ReBEC):: # RBR-7nkf8tn
SN  - 0100-7203
SN  - 1806-9339
ER  -